Exscalate4CoV

Exscalate4CoV

Biotechnology Research

Private-public consortium supported by the EU’s Horizon 2020 - Grant Agreement 101003551

About us

E4C is a public-private consortium supported by the European Commission’s Horizon 2020 tender for projects to counter the Coronavirus pandemic and improve the management and care of patients. At the core of E4C is Exscalate (EXaSCale smArt pLatform Against paThogEns), at present the most powerful and cost-efficient intelligent supercomputing platform in the world. Exscalate has a "chemical library" of 500 billion molecules and a processing capacity of more than 3 million molecules per second. The E4C consortium, coordinated by Dompé farmaceutici, is composed by 18 members from seven European countries.

Industry
Biotechnology Research
Company size
201-500 employees
Type
Partnership
Founded
2020

Updates

Affiliated pages

Similar pages

Browse jobs